Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma

Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma

BackgroundPemphigus vulgaris (PV) is a rare and severe autoimmune blistering disorder affecting the skin and mucous membranes, characterized by the production of autoantibodies against two desmosomal adhesion proteins, desmoglein 1 and 3. In patients with advanced squamous cell carcinoma of the skin...

Full description

Bibliographic Details
Main Authors: Rosalba Buquicchio, Valentina Mastrandrea, Sabino Strippoli, Davide Quaresmini, Michele Guida, Raffaele Filotico
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
Pemphigus vulgaris
desmoglein
immune check-point inhibitors
cemiplimab
anti-programmed-death-1
cutaneous squamous cell carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.691980/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.691980/full

Similar Items